Anterior cruciate ligament regeneration using mesenchymal stem cells and collagen type I scaffold in a rabbit model
- 1.1k Downloads
The objective of this study was to determine whether using mesenchymal stem cells (MSC) seeded in a collagen type I scaffold would be sufficient to regenerate the torn anterior cruciate ligament (ACL).
Anterior cruciate ligament transection was performed on both knees in 10 New Zealand rabbits and then repaired with as follows: suture alone (suture-treated group, n = 6), suture associated with collagen type I scaffold (collagen type I scaffold-treated group, n = 8) or suture associated with autologous MSC seeded on collagen type I scaffold (MSC/collagen type I scaffold-treated group, n = 6). At 12-week post-intervention, the animals were killed and the ACLs were characterised macroscopically and histologically. Data of the 3 groups were against normal ACL (normal group, n = 10).
Macroscopic observation found that in MSC/collagen type I scaffold group, 33 % of specimens showed a complete ACL regeneration, with a tissue similar to the normal ACL. Regeneration was not observed in the group treated with suture alone or associated with collagen type I scaffold without cells. In the latter, only a reparative attempt at the ends was observed. Histological analysis of the regenerated ACL showed a tissue with organised collagen and peripheric vessels.
These results provide evidence that the use of MSC seeded in a collagen type I scaffold in the treatment of ACL injuries is associated with an enhancement of ligament regeneration. This MSC-based technique is a potentially attractive tool for improving the treatment of ACL ruptures.
KeywordsAnterior cruciate ligament Mesenchymal stem cells Collagen type I scaffold Regeneration Tissue engineering
Conflict of interest
The authors declare that they have no conflict of interest.
- 8.Darabos N, Haspl M, Moser C, Darabos A, Bartolek D, Groenemeyer D (2011) Intraarticular application of autologous conditioned serum (ACS) reduces bone tunnel widening after ACL reconstructive surgery in a randomized controlled trial. Knee Surg Sports Traumatol Arthrosc 19(Suppl 1):S36–S46PubMedCrossRefGoogle Scholar
- 11.Fisher MB, Liang R, Jung H-J, Kim KE, Zamarra G, Almarza AJ, McMahon PJ, Woo SL-Y (2012) Potential of healing a transected anterior cruciate ligament with genetically modified extracellular matrix bioscaffolds in a goat model. Knee Surg Sports Traumatol Arthrosc 20:1357–1365PubMedCrossRefGoogle Scholar
- 17.Kobayashi K, Healey RM, Sah RL, Clark JJ, Tu BP, Goomer RS, Akeson WH, Moriya H, Amiel D (2000) Novel method for the quantitative assessment of cell migration: a study on the motility of rabbit anterior cruciate (ACL) and medial collateral ligament (MCL) cells. Tissue Eng 6:29–38PubMedCrossRefGoogle Scholar
- 19.Mastrokalos DS, Springer J, Siebold R, Paessler HH (2005) Donor site morbidity and return to the preinjury activity level after anterior cruciate ligament reconstruction using ipsilateral and contralateral patellar tendon autograft: a retrospective, nonrandomized study. Am J Sports Med 33:85–93PubMedCrossRefGoogle Scholar
- 20.Minguell JJ, Erices A, Conget P (2001) Mesenchymal stem cells. Exp Biol Med (Maywood) 226:507–520Google Scholar
- 27.Rość D, Powierza W, Zastawna E, Drewniak W, Michalski A, Kotschy M (2002) Post-traumatic plasminogenesis in intraarticular exudate in the knee joint. Med Sci Monit 8:371–378Google Scholar